Fusion Pharmaceuticals Inc. Annual Nonoperating Income (Expense) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Fusion Pharmaceuticals Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2019 to 2023.
  • Fusion Pharmaceuticals Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $1.95M, a 253% increase year-over-year.
  • Fusion Pharmaceuticals Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $6.52M.
  • Fusion Pharmaceuticals Inc. annual Nonoperating Income (Expense) for 2023 was $5.12M.
  • Fusion Pharmaceuticals Inc. annual Nonoperating Income (Expense) for 2022 was -$1.42M, a 266% decline from 2021.
  • Fusion Pharmaceuticals Inc. annual Nonoperating Income (Expense) for 2021 was $850K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.12M +$6.54M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-20
2022 -$1.42M -$2.27M -266% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-20
2021 $850K +$38.6M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 -$37.8M -$40.1M -1756% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
2019 $2.28M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.